About Akero Therapeutics
Akero Therapeutics, Inc. operates as a cardio-metabolic nonalcoholic steatohepatitis company, which engages in developing pioneering medicines designed to restore metabolic balance and improve overall health.
Akero Therapeutics (NASDAQ:AKRO) Frequently Asked Questions
6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Akero Therapeutics in the last year. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Akero Therapeutics stock. View analyst ratings for Akero Therapeutics or view top-rated stocks.
What is Altaba Yahoo?
What on earth is Altaba? This odd-sounding moniker (AltabaVista? Jessica Altaba?) is the new name for what's left of Yahoo. The core business of Yahoo is now owned by Verizon -- and it is becoming part of a separate unit of the telecom giant called Oath, which also includes AOL.
Did Yahoo sell its digital properties?
Yahoo sold its digital properties, like its fantasy sports, finance and news websites, as well as Yahoo Mail, Tumblr and Flickr, to Verizon ( VZ). But Yahoo held on to its stakes in the Chinese e-commerce giant Alibaba ( BABA) and Yahoo Japan ( YAHOF).
Is Altaba a holding company?
Altaba is essentially a holding company for Yahoo's remaining shares of Alibaba. But if Alibaba tried to buy those shares back to regain control, it would get hit with a huge tax bill. Yahoo said in a regulatory filing last year that it could be as high as 36.5%. So Altaba is sort of a no-man's-land stock.
What other stocks do shareholders of (ARMH) own?
Based on aggregate information from My MarketBeat watchlists, some companies that other (ARMH) investors own include 17119603 (ARM.L) (ARM), Starbucks (SBUX), Alphabet (GOOG), Intel (INTC), Netflix (NFLX), QUALCOMM (QCOM), Citigroup (C), NXP Semiconductors (NXPI), Tesla (TSLA) and Cisco Systems (CSCO).
What is (ARMH)'s stock price today?
One share of ARMH stock can currently be purchased for approximately $67.77.
